NIH-funded research NIH-funded research

Understanding how DNA replication timing affects genetic diseases and cancer

Official title: The Genetic Basis of Human DNA Replication Timing

Funded at Roswell Park Cancer Institute Corp · NIH-11002006 · Data updated 2026-11-12

This study is looking at how and when our DNA copies itself in order to better understand how problems with this process might lead to genetic diseases and cancer, which could help patients in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRoswell Park Cancer Institute Corp
NIH-funded
Lab location1 site (Buffalo, United States)
Project startMay 1, 2023
Project endFebruary 29, 2028
Funding year2025
Award (this year)$412,236
NIH project number5R35GM148071-03
Project IDNIH-11002006 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with genetic disorders or a family history of cancer.

Less likely to help

Patients with no genetic predisposition to diseases related to DNA replication timing may not receive benefit from this research.

What this research studies

This research investigates the timing of DNA replication across the human genome and its implications for genetic diseases and cancer. By developing innovative experimental and computational methods, the team aims to create the largest dataset of human DNA replication timing to date. They will explore how this timing interacts with gene expression and the epigenome, potentially revealing critical insights into the mechanisms that govern these processes. Patients may benefit from a deeper understanding of how abnormal DNA replication can lead to genetic disorders and cancer.

Why it matters

Potential benefit: If successful, this research could lead to new insights into the genetic basis of diseases and inform future therapeutic strategies.

How similar studies have gone: Previous research has shown promising results in linking DNA replication timing to genetic variation, indicating that this approach has potential for significant discoveries.

Where this research is happening

  • Roswell Park Cancer Institute Corp
    Buffalo, United States
    Active

Researchers

  • Principal investigator: Koren, Amnon — Roswell Park Cancer Institute Corp
  • Study coordinator: Koren, Amnon

Related research

Other NIH-funded projects on the same topics.

  • A network for sharing data and resources in immuno-oncology.

    This study is all about bringing together experts to find better ways to treat cancer by understanding why some treatments don’t work and discovering new targets for the immune system, which could lead to more personalized and effective therapies for adults.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-9889667

  • A network for sharing data and resources in immuno-oncology

    This study is all about finding better ways to treat cancer using the body's immune system by working together with different experts to share information, which could lead to new treatments and help patients like you have more effective options.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-9625289

  • Targeting retrotransposons to help kids with hard-to-treat cancers like neuroblastoma

    Aims to repurpose safe antiviral drugs to block retrotransposons in children with relapsed or refractory neuroblastoma to improve outcomes.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11535292

  • MedSupport: Helping families overcome barriers to kids' chemotherapy medicines

    This program offers extra support to parents of children with acute lymphoblastic leukemia to help them give home chemotherapy medicines more reliably.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11508243

  • Innate immune cells and female lung cancer risk

    A study exploring how certain immune cells in the lungs may contribute to lung cancer in young women who don’t smoke.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11455512

  • Effect of ONP filler materials on how fast nicotine is delivered

    This grant tests how different filler materials in oral nicotine pouches affect how quickly nicotine is released and absorbed in the mouth.

    NIH research Roswell Park Cancer Institute Corp · Buffalo, United States · NIH-11455485

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.